Author:
Bortolussi Giulia,Muro Andrés F.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology, and Child Health
Reference144 articles.
1. Seppen, J. et al. Discrimination between Crigler–Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J. Clin. Investig. 94, 2385–2391 (1994).
2. Memon, N., Weinberger, B. I., Hegyi, T. & Aleksunes, L. M. Inherited disorders of bilirubin clearance. Pediatr. Res. 79, 378–386 (2016).
3. American Academy of Pediatrics Subcommittee on H. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114, 297–316 (2004).
4. Ullah, S., Rahman, K. & Hedayati, M. Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures and treatments: a narrative review article. Iran. J. Public Health 45, 558–568 (2016).
5. Sedlak, T. W. & Snyder, S. H. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113, 1776–1782 (2004).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献